Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bone Expansion”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06426719
What this trial is testing

Efficiency of Using Osseodensification Protocol

Who this might be right for
Alveolar Bone Resorption
Mohamed Magdy Mostafa Shehata 18
Testing effectiveness (Phase 2)Ended earlyNCT02440685
What this trial is testing

Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors

Who this might be right for
Lymphoma, Large B-Cell, DiffuseLymphoma, Mantle-CellLymphoma, Follicular+18 more
Asana BioSciences 51
Testing effectiveness (Phase 2)Ended earlyNCT02712905
What this trial is testing

An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 116
Testing effectiveness (Phase 2)Looking for participantsNCT06206174
What this trial is testing

TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies

Who this might be right for
Hematologic MalignancyNon Hodgkin LymphomaAcute Myeloid Leukemia+2 more
Shenzhen TargetRx Co., Ltd. 30
Testing effectiveness (Phase 2)Ended earlyNCT03422679
What this trial is testing

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Who this might be right for
Breast CancerColorectal CancerAdenoid Cystic Carcinoma+5 more
Cellestia Biotech AG 79
Early research (Phase 1)WithdrawnNCT03414450
What this trial is testing

Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies

Who this might be right for
Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)Ph- Acute Lymphoblastic Leukemia (Ph-ALL)Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+)+1 more
EDDC (Experimental Drug Development Centre), A*STAR Research Entities
Testing effectiveness (Phase 2)Study completedNCT04265651
What this trial is testing

Study of Infigratinib in Children With Achondroplasia

Who this might be right for
Achondroplasia
QED Therapeutics, a BridgeBio company 84
Early research (Phase 1)Not Yet RecruitingNCT07616089
What this trial is testing

Phase I Study of FXS0683 in the Treatment of Blood Tumors

Who this might be right for
B-Cell LymphomaAcute Myeloid LeukemiaMyelodysplastic Syndromes+1 more
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 228
Testing effectiveness (Phase 2)Looking for participantsNCT07761533
What this trial is testing

PBSS1113 in Combination With Azacitidine to Treat Patients With AML/MDS

Who this might be right for
Acute Myeloid Leukemia (AML)MDS (Myelodysplastic Syndrome)
Chaser Therapeutics, Inc. 29
Not applicableUnknownNCT03065803
What this trial is testing

Buccal Plate Expansion Technique Versus Guided Bone Regeneration Technique in Socket Preservation in the Aesthetic Zone.

Who this might be right for
Bone Resorption After Tooth Extraction
Passant Khaled Tayaa 20
Early research (Phase 1)Study completedNCT02081378
What this trial is testing

A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL

Who this might be right for
Chronic Myelogenous LeukemiaPhiladelphia Chromosome-positive Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 326
Testing effectiveness (Phase 2)Study completedNCT00001566
What this trial is testing

A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

Who this might be right for
Ewing's SarcomaRhabdomyosarcoma
National Cancer Institute (NCI) 42
Not applicableStudy completedNCT06912568
What this trial is testing

Three-dimensional CBCT Analysis of Root Volume Changes Following Tooth-bone and Bone-borne Maxillary Expansion: A Pilot Study.

Who this might be right for
Root ResorptionOrthodontic ApplianceCBCT Segmentation
University of Roma La Sapienza 21
Not applicableLooking for participantsNCT07331207
What this trial is testing

The Effect of 3D Printed Framework Bone-Borne Rapid Maxillary Expander in Young Adults

Who this might be right for
Bone Anchored Miniscrew Assisted Rapid Palatal Expansion
Mansoura University 16
Testing effectiveness (Phase 2)UnknownNCT01209611
What this trial is testing

Autologous Bone Marrow-Derived Mononuclear Cell Transplantation in Accelerating Tissue Expansion and Skin Regeneration

Who this might be right for
Tissue Expansion;Skin Regeneration;Reconstruction;+1 more
Shanghai Jiao Tong University School of Medicine 30
Not applicableStudy completedNCT07272694
What this trial is testing

Split Crest Procedure: Is It Necessary to Fill the Gap?

Who this might be right for
Alveolar Bone ResorptionAlveolar Bone GraftingBone Expansion
Vladimir Biocanin 24
Testing effectiveness (Phase 2)Ended earlyNCT02711137
What this trial is testing

Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumors
Incyte Corporation 137
Not applicableLooking for participantsNCT06146231
What this trial is testing

Motiva Flora® Aesthetic Breast Recon® Clinical Study

Who this might be right for
MammaplastyBreast CancerPoland Syndrome
Establishment Labs 66
Early research (Phase 1)Ended earlyNCT03144661
What this trial is testing

An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies

Who this might be right for
Hepatocellular Carcinoma (HCC)CholangiocarcinomaEsophageal Cancer+3 more
Incyte Corporation 25
Testing effectiveness (Phase 2)UnknownNCT03091933
What this trial is testing

Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)

Who this might be right for
Hematologic CancerRelapse LeukemiaRelapsed Adult ALL+6 more
Ciusss de L'Est de l'Île de Montréal 20
Next Page